biologics-bone tissue
New York Stem Cell Summit 2012
Osprey Biomedical Corp.
BoneShark
Pioneer Surgical
 
Simply Innovative by spineart
OsteoMed
OMTEC 2012
MTF 2011
Hydrolift by AESCULAP
Medical Capital Advisors
Pearl Diver
New York Stem Cell Summit 2012

New York Stem Cell Summit Preview
Robin Young • Tue, Jan 10th, 2012

 

Reflecting the dynamic nature of the industry, this year’s Stem Cell Summit has a record number of new presenters and one notable drop out—Geron. No question, adult stem cells are king of the hill for clinicians, but are embryonic stem cell therapies gone for good? The answer may surprise. Read on.

Inherit the Wind starring Spencer Tracy, Frederick March and Harry Morgan. Courtesy Wikimedia Commons

Carragee for the Prosecution
Robin Young • Mon, Dec 5th, 2011

 

In the recent issue of The Spine Journal, Eugene Carragee, M.D., writes more like prosecutor-in-chief than editor-in-chief as he resumes his attack on the use of rhBMP2 and its clinical investigators. The plaintiff’s bar is cheering. But NASS members are reeling. Who to believe? Read the details here.

Image created by RRY Publications, LLC. Source: MiMedx

Answer: Traction, a Screw and MiMedx
Robin Young • Tue, Oct 11th, 2011

 

Question: What are three terrific new technologies or companies in orthopedics? We see new product ideas and companies every week, but these three recent candidates stood out for their innovation and practicality. See if you agree.

Image creation by RRY Publications, LLC. Source: Wikimedia Commons

Five Stem Cell Companies in Orthopedics
Robin Young • Mon, Aug 22nd, 2011
1 Comment

 

Five companies, we think, stand out when it comes to non-allograft stem cells. These firms either have stem cell products on the market or are in the very advanced stages of bringing therapeutic stem cells to the rank and file orthopedic surgeon. Check it out.

Source: Wikimedia Commons and Alejandro zorrilal Cruz

The Ten Most Disruptive Trends in Orthopedics
Robin Young • Mon, Aug 15th, 2011

 

Ten potentially disruptive trends are gathering momentum. Some or all of these, we think, will change orthopedics forever. From least to most, here are our picks for the coming disruptive trends in products, services, hospitals and employment in orthopedics.

Photo manipulation by RRY Publications. Source: Wikimedia and Jack Gilmour

InFuse - Part II
Robin Young • Tue, Jul 19th, 2011

 

This week, in Part II of our review of The Spine Journal’s BMP issue, we tackle some of the other issues raised by the Journal, notably corporate funding of the InFuse studies. Then we look at the broader implications of the Journal’s review on innovation and self-regulation in the spine surgery community.

Source: RRY Publications

InFuse - Part I
Robin Young • Mon, Jul 11th, 2011

 

First The Spine Journal devotes its entire June 29th issue to repudiating studies—one of which once appeared in its own pages. Then a Wall Street analyst speculated that Medtronic might divest itself of InFuse or Spine or both. Surgeons are upset. It’s a mess. Using PearlDiver data we try to sort fact from fiction.